The Retail Price vs. What People Actually Pay
The list prices for brand-name GLP-1 medications look alarming: Wegovy carries a wholesale acquisition cost near $1,349 per month, and Zepbound runs around $1,060 per month. But these list prices are almost never what patients actually pay. Between manufacturer programs, savings cards, telehealth options, and new direct-to-patient pricing, the real cost landscape in 2026 is far more accessible than the sticker shock suggests.
Manufacturer Direct-to-Patient Programs
Both major GLP-1 manufacturers now offer their own cash-pay programs that bypass traditional pharmacy pricing.
Novo Nordisk (Wegovy, Ozempic)
Through NovoCare Pharmacy, Novo Nordisk offers Wegovy injectable at $199 per month for the first two fills (0.25mg and 0.5mg starting doses), then $349 per month for ongoing fills. The Wegovy pill is available starting at $149 per month for the lowest doses (1.5mg and 4mg), with the maintenance 25mg dose at $299 per month. With commercial insurance, the Wegovy savings card can reduce your copay to as little as $25 per month.
Eli Lilly (Foundayo, Zepbound)
Through LillyDirect, Foundayo starts at $149 per month for the starting dose, with intermediate doses at $199 and maintenance at $299 per month. Zepbound KwikPens start at $299 per month for the 2.5mg dose, with higher doses ranging from $399 to $449. Lilly's savings card for commercially insured patients can reduce Zepbound to as little as $25 per month.
Patient Assistance Programs (Free or Near-Free Medication)
Both manufacturers operate patient assistance programs (PAPs) for low-income, uninsured patients. The NovoCare PAP covers Ozempic and some other products for patients whose household income is at or below 200% of the federal poverty level (roughly $30,120 for a single person in 2026). Lilly Cares covers Mounjaro and Trulicity at no cost for eligible uninsured patients, with an income threshold at or below 300% of the federal poverty level. These programs require a doctor's prescription, proof of income, and proof of insurance status. Processing takes 2 to 4 weeks.
Telehealth and Compounded Options
Telehealth platforms offering compounded GLP-1 formulations represent the most affordable access point for many patients. Compounded semaglutide typically runs $149 to $299 per month through established telehealth providers, and compounded tirzepatide ranges from $189 to $399 per month. These prices usually include the provider consultation and medication.
Pharmacy Discount Cards
GoodRx, SingleCare, and RxSaver negotiate pricing through pharmacy benefit managers and can reduce cash prices at retail pharmacies. GoodRx currently offers Ozempic and Wegovy at $199 for the first two fills, then $299 to $349 per month. These discounts cannot be combined with insurance or manufacturer savings cards — they're specifically for cash-paying customers.
FSA and HSA Accounts
If you have access to a Flexible Spending Account (FSA) or Health Savings Account (HSA), GLP-1 medications are eligible expenses when prescribed by a licensed provider. This effectively gives you a 22 to 37 percent tax savings on the cost, depending on your tax bracket. FSA contributions are capped at $3,400 for 2026. Telehealth consultation fees and compounded medication costs are generally eligible as well — confirm with your plan administrator.
Medicare GLP-1 Bridge (Starting July 2026)
Medicare Part D beneficiaries who meet the Bridge program's eligibility criteria can access Wegovy, Foundayo, and Zepbound at a flat $50 per month copay starting July 1, 2026. This is a significant development for the 65-and-older population, who were previously excluded from nearly all GLP-1 savings programs.
Cost Comparison at a Glance
| Access Pathway | Monthly Cost Range | Who Qualifies |
|---|---|---|
| Retail (no discounts) | $900–$1,400 | Anyone with a prescription |
| Manufacturer programs | $149–$449 | Self-pay patients (no gov. insurance) |
| Insurance + savings card | $25–$200 | Commercially insured + PA approval |
| Compounded (telehealth) | $149–$399 | Anyone with a telehealth prescription |
| Patient assistance programs | $0 | Low-income, uninsured |
| Medicare Bridge | $50 | Eligible Part D beneficiaries (July 2026+) |
Hidden Costs to Budget For
Beyond the medication itself, factor in telehealth consultation fees ($0 to $99 per visit, varies by platform), syringes and alcohol swabs if using injectable formulations (approximately $5 to $15 per month), lab work for monitoring (lipid panel, A1C, basic metabolic panel — may be covered by insurance even if the medication isn't), and shipping costs if using a mail-order pharmacy (many platforms include free shipping).